Curtiss-Wright (CW) Form 144: Notice to Sell 3,750 Shares on NYSE

Curtiss-Wright (CW): A selling securityholder filed a Form 144 for Curtiss‑Wright common stock, indicating an intended sale of 3,750 shares on the NYSE, through UBS Financial Services, Inc., with an aggregate market value of $2,166,705.75.

Accepted by SEC EDGAR 11/12/2025 - 09:55 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Curtiss-Wright (CW): A selling securityholder filed a Form 144 for Curtiss‑Wright common stock, indicating an intended sale of 3,750 shares on the NYSE, through UBS Financial Services, Inc., with an aggregate market value of $2,166,705.75. The filing lists an approximate sale date of 11/12/2025.

The securities to be sold were acquired via RSU grants from the issuer: 3,300 shares on 03/18/2024 and 450 shares on 02/05/2024. Shares outstanding were 36,874,638; this is a baseline figure, not the amount being sold.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Curtiss-Wright (CW) shares are covered by this Form 144?

The notice indicates an intended sale of 3,750 shares of Curtiss‑Wright common stock.

What is the aggregate market value disclosed in the CW Form 144?

The filing lists an aggregate market value of $2,166,705.75 for the proposed sale.

When is the approximate sale date for the CW shares?

The approximate date of sale disclosed is 11/12/2025.

Which broker and exchange are named for the CW sale?

The filing names UBS Financial Services, Inc. as broker and NYSE as the exchange.

How were the CW shares to be sold acquired?

They were acquired via RSU grants from the issuer: 3,300 on 03/18/2024 and 450 on 02/05/2024.

How many Curtiss-Wright shares were outstanding?

Shares outstanding were 36,874,638.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001836013
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CURTISS WRIGHT CORP
SEC File Number	001-00134
Address of Issuer	130 HARBOUR PLACE DRIVE SUITE 300 DAVIDSON NORTH CAROLINA 28036
Phone	7048694600
Name of Person for Whose Account the Securities are To Be Sold	Bamford Lynn M
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	3750	2166705.75	36874638	11/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/18/2024	RSU	Issuer			3300	03/18/2024	N/A
Common	02/05/2024	RSU	Issuer			450	02/05/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	This filing is for shares executed on 11/11/2025 and filed on 11/12/2025 due to the SEC closure for Veterans Day.
Date of Notice	11/12/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services, Inc. as attorney-in-fact for Lynn Bamford
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)